$INO Recent Headlines Monday's biggest gaining and

New Post Public Reply Private Reply Replies (0) Message Board

Feb 24, 2014 at 11:22 AM

$INO Recent Headlines

Monday's biggest gaining and declining stocks 4:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 11:31 a.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 9:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 10:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 5:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 5:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 4:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 5:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 5:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 9:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 6:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 6:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 9:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 5:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 5:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 5:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 5:05 a.m. May 12, 2005 - Steve Goldstein

Eotaxin-1 Inhibition - The Next PD(L)-1 In Inflammatory Disease? 10:23 a.m. Feb. 21, 2014 - Seeking Alpha
The REAL Inovio Pharmaceuticals: An Interview With Dr. J. Joseph Kim, CEO 4:14 p.m. Feb. 19, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock Is Inovio Pharmaceuticals (INO) 9:45 a.m. Feb. 13, 2014 - TheStreet.com
Inovio Pharmaceuticals (INO) Showing Signs Of Perilous Reversal Today 9:52 a.m. Feb. 12, 2014 - TheStreet.com
Inovio Pharmaceuticals (INO) Moving On Heavy Pre-Market Trading 9:17 a.m. Feb. 11, 2014 - TheStreet.com
Inovio Pharmaceuticals, Inc. (INO) Jumps: Stock Up 6.2% - Tale of the Tape 8:51 a.m. Feb. 11, 2014 - Zacks.com
Inovio IL-33 Results Provide Further Validation Of Platform 11:19 a.m. Feb. 3, 2014 - Seeking Alpha
Inovio Neglected The Sign: Don't Feed The Bears! 3:58 a.m. Feb. 2, 2014 - Seeking Alpha
OncoSec Executives Talk Electroporation, PD-1 Checkpoint Inhibitors, And The Unmet Need In Immune-Oncology 9:20 a.m. Jan. 29, 2014 - Seeking Alpha
6 Biotechnology Stocks to Buy Now 6:00 a.m. Jan. 29, 2014 - InvestorPlace.com
Inovio - Sitting At The Pot Of Gold 8:26 a.m. Jan. 24, 2014 - Seeking Alpha
Advaxis And Inovio Race For First Cervical Cancer Immunotherapy 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
Electroporation: Looking Ahead at 2014 11:17 a.m. Jan. 21, 2014 - Wall St. Cheat Sheet
Buyout Picks In Healthcare For 2014 7:05 a.m. Jan. 10, 2014 - Seeking Alpha
Biotech Stock Mailbag: NeoStem, MannKind, Inovio 6:00 a.m. Jan. 10, 2014 - TheStreet.com
Mid-Afternoon Market Update: Markets Mixed as Airlines Show a Boost in Traffic 2:31 p.m. Jan. 3, 2014 - benzinga.com
Inovio, Chelsea struggle after Feuerstein mention 11:58 a.m. Jan. 3, 2014 - Seeking Alpha
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Today's Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 9:48 a.m. Dec. 27, 2013 - TheStreet.com

Emeritus agrees to be acquired by Brookdale Senior Living; Wal-Mart to spend more than $200M on investigations in the next fiscal year 12:26 a.m. Today - ACCESSWIRE
Inovio Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference 4:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immunotherapies 4:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference 4:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Unveils Potent New Immune Activator 4:00 a.m. Jan. 23, 2014 - PR Newswire - PRF
Market Technicals Simplified: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 7:33 a.m. Jan. 16, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference 4:00 a.m. Jan. 6, 2014 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 8:23 a.m. Dec. 17, 2013 - PR Newswire
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel 8:05 a.m. Dec. 11, 2013 - PR Newswire
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial 3:05 a.m. Nov. 20, 2013 - PR Newswire
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:03 a.m. Nov. 19, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees 4:00 a.m. Nov. 19, 2013 - PR Newswire
International Vaccine Institute Announces Appointments of New Members to its Board of Trustees 8:00 p.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences 4:00 a.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Receives 2013 Drug Discovery & Achievement Award 12:00 a.m. Nov. 14, 2013 - PR Newswire
Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results 6:33 a.m. Nov. 12, 2013 - PR Newswire
Inovio Pharmaceuticals to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013 9:32 a.m. Nov. 11, 2013 - ACCESSWIRE
Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 12, 2013 4:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial 3:00 a.m. Oct. 21, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractal Sees Explosive Q2 Gain: Revenue Hits $100M

Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...

Micropos Medical's Push in High-Precision Radiotherapy

Micropos Medical's Bold Steps into Radiotherapy Let's put a spotlight on a niche that's crying for attention: Micropos Medical is making waves in how we treat prostate cancer. They're leveraging technology with their Raypilot System, and they're partnering with the big guns at Johns Hopkins Medicine. Think about it — five patients in the U.S. are already seeing how this...

Metals Producers Rise Despite Futures Dip: Election Day Buzz

Election Day Drama: Metals Market Jitters You'd think with all the election day hoopla, the metal futures would hold steady. But here we are, seeing gold, silver, and copper futures retracting like a scared turtle. Monday, they all roared upward. Tuesday morning, they're backpedaling. December gold futures took a hit, dropping 0.78% to land at $3,938.50 an ounce. Silver...

Kaolin Market Surges to $8.89B by 2031: Key Trends

Riding the Kaolin Wave: Industrial Market Expansion You can't miss the sound of kaolin clinking in as it rides the tide of industrial demand. Reports from MarketsandMarkets™ have kaolin's party rocking all the way to a hefty $8.89 billion by 2031, up from $6.19 billion in 2026. With a sensible 7.5% compound annual growth rate (CAGR), this clay’s is aiming for the...

PASCO scientific Appoints David Lopez as New CEO

New Leadership at PASCO scientific Here's the scoop: PASCO scientific is shaking things up at the top by welcoming David Lopez into the CEO chair as of October 5, 2026. Lopez comes packing over two decades of experience in education and organizational leadership. He's stepping into a legacy that's all about making science hands-on and exciting for students—not just in...

Scage Future's Next Leap: Mining with Autonomy

Scage Future Drives Change with NCMCC Partnership Ever hear a platoon of autonomous trucks gearing up, ready to redefine the mining sector? That's exactly what’s brewing between Scage Future and China Huaye Group Co., Ltd. (NCMCC) from the latest update right out of Nanjing. Breaking Down the Deal They've slapped their signature on a non-binding agreement as of...

SecureSpace Expands into Dallas-Fort Worth Market

A New Player in Dallas-Fort Worth SecureSpace Self Storage has stormed into the Dallas-Fort Worth area, ushering in a sizeable expansion with four brand-new locations. This move is big news for the self-storage operator, marking its very first foray into the Texan market and boosting its nationwide presence past that century mark – 101 stores and counting. Call it a...

WeSalute's 'Heroes Meet Heroes' Unites Military, Athletes

Every now and then, something stirs the soul in a way that neither Wall Street nor Main Street quite can. The 14th annual 'Heroes Meet Heroes' event by WeSalute is poised to do just that. Celebrating Service Through Shared Experiences WeSalute has been a cornerstone for veteran recognition for over two decades, fostering a sense of unity between military service members...

Silvercorp Updates El Domo Budget Amid Challenges

Budget Pains for Silvercorp's El Domo Project Folks, if you thought navigating the stock market was a minefield, try mining these days. Silvercorp Metals Inc. had to bump up its budget for the El Domo project in Ecuador—again. This time by $14.6 million. What's causing this fiscal heartache? Everything from rising diesel prices thanks to Ecuador playing games with...

Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....